The Effect of Transcranial Magnetic Stimulation Combined with Risperidone in the Treatment of Schizophrenia Patients and the Occurrence of Cognitive Function and Adverse Reactions
Abstract
schizophrenia, as well as the cognitive function and adverse reactions. Methods: The study period was from January 2024 to January 2025.
A total of 48 patients with schizophrenia who visited our hospital were collected as the research subjects. They were randomly divided into a
control group and an observation group, each consisting of 24 patients. The control group received risperidone alone, while the observation
group received TMS combined with risperidone. The treatment effects, cognitive functions, mental states, and adverse reactions of the two
groups were compared. Results: After treatment, the total effective rate of the observation group was higher than that of the control group
(P < 0.05). Before the implementation of different nursing plans, there was no significant difference in cognitive function and mental state
scores between the two groups. After the implementation, the cognitive function scores of the observation group were higher than those of the
control group, and the scores of various mental symptoms of the patients in the observation group were lower than those in the control group,
with statistically significant differences (P < 0.05). The incidence of adverse reactions after treatment in the observation group was relatively
lower, and the difference was statistically significant (P < 0.05). Conclusion: The combination of TMS and risperidone in the clinical treatment of schizophrenia has more prominent effects, significantly improves the mental symptoms and cognitive function of patients, and has
good safety, which is worthy of clinical adoption.
Keywords
Full Text:
PDFReferences
[1] Zhang Xianqiang, Zhu Yanling, Lv Shuang. The effect of low-frequency repetitive transcranial magnetic stimulation combined with
risperidone on delusional symptoms and concomitant emotional symptoms in schizophrenia [J]. Chinese and Foreign Medical Research,
2023, 2(28): 57-59.
[2] Lin Yin, Chen Shengli, Luo Haidong. The effect of repetitive transcranial magnetic stimulation combined with risperidone on preventing relapse and improving cognitive function in elderly patients with schizophrenia [J]. Chinese Journal of Gerontology, 2023, 43(24):
5958-5960.
[3] Guan Haiyan, Shi Feng, Gao Zhitao, et al. The effect of repetitive transcranial magnetic stimulation combined with risperidone on children and adolescents with schizophrenia [J]. International Journal of Psychiatry, 2023, 50(2): 229-231.
[4] Zhou Yuhua, Cao Zhengui. Clinical comparative analysis of repetitive transcranial magnetic stimulation combined with electroconvulsive therapy without convulsions and risperidone in the treatment of refractory schizophrenia in homeless patients [J]. Medical Theory
and Practice, 2022, 35(3): 402-404.
[5] Feng Yang, Xu Jingwen, Guan Xiaobo, et al. The efficacy and safety of repetitive transcranial magnetic stimulation on negative symptoms and cognitive function in patients with schizophrenia [J]. Journal of Clinical Psychiatry, 2023, 33(4): 288-291.
[6] Yan Chuandong, Wang Peng, Fang Maosheng. The effect of risperidone, rTMS combined with supportive family psychotherapy on social function and mental health in patients with schizophrenia and auditory hallucinations [J]. Chinese Journal of Clinical Psychology,
2023, 31(6): 1531-1535.
[7] Shao Yingze. Clinical effect observation of repetitive transcranial magnetic stimulation combined with electroconvulsive therapy without convulsions and risperidone in the treatment of schizophrenia patients [J]. Reflex Therapy and Rehabilitation Medicine, 2021, 2(23):
83-86.
[8] Yang Yang, Zhou Jun, Wang Kangheng. The efficacy of rTMS combined with risperidone in the treatment of elderly patients with schizophrenia dominated by negative symptoms and its influence on cognitive function and serum hs-CRP, Hcy levels [J]. Chinese Journal of
Gerontology, 2023, 43(11): 2649-2652.
[9] Kong Caihong, Shen Biahong, Qiu Lingshan, et al. The effect of repetitive transcranial magnetic stimulation on mental symptoms and
cognitive function in elderly patients with schizophrenia [J]. Chinese Modern Doctor, 2022, 60(17): 121-124.
[10] Zhang Xianqiang, Lv Shuang, Zhong Yulong, et al. The effect of risperidone combined with low-frequency repetitive transcranial magnetic stimulation on patients with schizophrenia and its influence on serum dopamine concentration [J]. Chinese Journal of Contemporary Medicine, 2021, 28(15): 16-19.
[11] Feng Yang, Xu Jingwen, Guan Xiaobo, et al. Efficacy and Safety of Repetitive Transcranial Magnetic Stimulation on Negative Symptoms in Schizophrenia Patients during the Critical Period [J]. Shanxi Medical Journal, 2022, 51(15): 1687-1691.
[12] Wu Zhenhong. Clinical Effect of Repetitive Transcranial Magnetic Stimulation Combined with Risperidone in Treating Auditory Hallucinations in First-Episode Schizophrenia Patients [J]. Journal of Clinical Rational Drug Use, 2022, 15(28): 1-3+7.
[13] Yang Ju, Luo Xinggang, Li Qingjun. Effects of Risperidone Combined with Low-Frequency Repetitive Transcranial Magnetic Stimulation on Intractable Auditory Hallucinations in Schizophrenia and Its Impact on Event-Related Potentials [J]. Journal of Practical Hospital Clinical Medicine, 2022, 19(4): 169-173.
DOI: http://dx.doi.org/10.70711/mhr.v2i7.7442
Refbacks
- There are currently no refbacks.
